tradingkey.logo

CorVel Corp

CRVL
48.670USD
-0.060-0.12%
Close 02/06, 16:00ETQuotes delayed by 15 min
2.49BMarket Cap
23.63P/E TTM

CorVel Corp

48.670
-0.060-0.12%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of CorVel Corp

Currency: USD Updated: 2026-02-06

Key Insights

CorVel Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 62 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

CorVel Corp's Score

Industry at a Glance

Industry Ranking
62 / 75
Overall Ranking
343 / 4521
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

CorVel Corp Highlights

StrengthsRisks
CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 24.64% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 895.59M.
Fairly Valued
The company’s latest PE is 23.63, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 28.07M shares, increasing 0.01% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 8.98K shares of this stock.

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of CorVel Corp is 9.02, ranking 9 out of 75 in the Healthcare Providers & Services industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 235.62M, representing a year-over-year increase of 3.36%, while its net profit experienced a year-over-year increase of 1.70%.

Score

Industry at a Glance

Previous score
9.02
Change
0

Financials

10.00

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

8.12

Operational Efficiency

9.21

Growth Potential

10.00

Shareholder Returns

7.77

CorVel Corp's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of CorVel Corp is 3.70, ranking 75 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 23.63, which is 12215.09% below the recent high of 2910.17 and 1199.29% above the recent low of -259.77.

Score

Industry at a Glance

Previous score
3.70
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 62/75
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for CorVel Corp. The Healthcare Providers & Services industry's average is 7.58.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of CorVel Corp is 6.70, ranking 45 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 65.22 and the support level at 39.58, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.72
Change
-0.02

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(4)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-4.846
Sell
RSI(14)
20.482
Sell
STOCH(KDJ)(9,3,3)
9.396
Oversold
ATR(14)
3.845
High Vlolatility
CCI(14)
-139.027
Sell
Williams %R
93.311
Oversold
TRIX(12,20)
-0.642
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
53.562
Sell
MA10
61.247
Sell
MA20
65.372
Sell
MA50
68.091
Sell
MA100
71.647
Sell
MA200
85.652
Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of CorVel Corp is 5.00, ranking 49 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 55.26%, representing a quarter-over-quarter increase of 0.04%. The largest institutional shareholder is The Vanguard, holding a total of 3.23M shares, representing 6.32% of shares outstanding, with 0.62% increase in holdings.

Score

Industry at a Glance

Previous score
5.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Corstar Holdings, Inc.
18.74M
-0.58%
Kayne Anderson Rudnick Investment Management, LLC
5.45M
-1.91%
BlackRock Institutional Trust Company, N.A.
4.16M
+7.10%
The Vanguard Group, Inc.
Star Investors
3.28M
+1.38%
Clemons (Victor Gordon)
2.47M
--
Renaissance Technologies LLC
Star Investors
1.77M
-1.19%
Dimensional Fund Advisors, L.P.
1.25M
-2.93%
State Street Investment Management (US)
1.15M
+5.02%
Geode Capital Management, L.L.C.
899.18K
+6.33%
Michael (Jeffrey J)
543.20K
+1.48%
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of CorVel Corp is 8.40, ranking 10 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 1.11. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
8.40
Change
0
Beta vs S&P 500 index
1.11
VaR
+3.22%
240-Day Maximum Drawdown
+58.98%
240-Day Volatility
+36.14%

Return

Best Daily Return
60 days
+3.75%
120 days
+5.69%
5 years
+10.98%
Worst Daily Return
60 days
-26.05%
120 days
-26.05%
5 years
-26.05%
Sharpe Ratio
60 days
-2.64
120 days
-2.43
5 years
+0.31

Risk Assessment

Maximum Drawdown
240 days
+58.98%
3 years
+62.11%
5 years
+62.11%
Return-to-Drawdown Ratio
240 days
-0.92
3 years
-0.12
5 years
+0.08
Skewness
240 days
-4.48
3 years
-2.22
5 years
-1.59

Volatility

Realised Volatility
240 days
+36.14%
5 years
+32.78%
Standardised True Range
240 days
+5.60%
5 years
+4.45%
Downside Risk-Adjusted Return
120 days
-233.31%
240 days
-233.31%
Maximum Daily Upside Volatility
60 days
+20.53%
Maximum Daily Downside Volatility
60 days
+55.02%

Liquidity

Average Turnover Rate
60 days
+0.30%
120 days
+0.28%
5 years
--
Turnover Deviation
20 days
+104.68%
60 days
+115.92%
120 days
+106.23%

Peer Comparison

Healthcare Providers & Services
CorVel Corp
CorVel Corp
CRVL
5.49 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ensign Group Inc
Ensign Group Inc
ENSG
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Encompass Health Corp
Encompass Health Corp
EHC
8.63 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Quest Diagnostics Inc
Quest Diagnostics Inc
DGX
8.62 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cigna Group
Cigna Group
CI
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Labcorp Holdings Inc
Labcorp Holdings Inc
LH
8.44 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI